US 11453667
Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor
granted A61KA61K31/519A61P
Quick answer
US patent 11453667 (Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor) held by Medshine Discovery Inc. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00